Newsquawk Logo

Abivax (ABVX FP) CEO says the latest funding round has permitted a move towards launching its bowel disease drug in the US without requiring 3rd party support, CNBC

ByNewsquawk Staff
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#EU SESSION#EUROPEAN EQUITIES
Published: Updated:
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.